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Abstract
m- and m-calpain are cysteine proteases requiring micro-
and millimolar Ca2q concentrations for their activation in
vitro. Among other mechanisms, interaction of calpains
with membrane phospholipids has been proposed to
facilitate their activation by nanomolar wCa2qx in living
cells. Here the interaction of non-autolysing, C115A
active-site mutated heterodimeric human m-calpain with
phospholipid bilayers was studied in vitro using protein-
to-lipid fluorescence resonance energy transfer and
surface plasmon resonance. Binding to liposomes was
Ca2q-dependent, but not selective for specific phospho-
lipid head groups. wCa2qx0.5 for association with lipid
bilayers was not lower than that required for the exposure
of hydrophobic surface (detected by TNS fluorescence)
or for enzyme activity in the absence of lipids. Deletion
of domain V reduced the lipid affinity of the isolated small
subunit (600-fold) and of the heterodimer (10- to 15-fold),
thus confirming the proposed role of domain V for
membrane binding. Unexpectedly, mutations in the acid-
ic loop of the ‘C2-like’ domain III, a putative Ca2q and
phospholipid-binding site, did not affect lipid affinity. Tak-
en together, these results support the hypothesis that in
vitro membrane binding of m-calpain is due to the
exposed hydrophobic surface of the active conformation
and does not reduce the Ca2q requirement for activation.
Keywords: acidic loop; C2 domain; Ca2q requirement;
domain V; membrane binding; surface plasmon
resonance.
Introduction
Calpains (EC 3.4.22.52) are intracellular cysteine protein-
ases exhibiting a unique dependence on Ca2q for enzyme
Present address: Protease Platform, Novartis Institutes fora
BioMedical Research, CH-4002 Basel, Switzerland.
activity. Members of the calpain superfamily have been
found from lower organisms, plants and invertebrates
through to mammals. As known so far, their functions are
related to cytoskeleton remodelling, signal transduction,
cell cycle regulation and cell death pathways (see Goll
et al., 2003, for a review). The best characterised mam-
malian calpains are the ubiquitous m- and m-isoforms,
heterodimeric enzymes activated in vitro by Ca2q con-
centrations of 3–50 mM and 0.4–0.8 mM, respectively.
They are inhibited by nanomolar concentrations of their
endogenous inhibitor, calpastatin (see Wendt et al., 2004,
for a review).
m-Calpain (mCP) and m-calpain (mCP) comprise
homologous, 80-kDa, large (L) ‘catalytic’ subunits and a
common, 28-kDa, small (S) ‘regulatory’ subunit. Activa-
tion of the calpains by Ca2q, resulting in the formation of
a functional active site from subdomains IIa and IIb of
the L-subunit, has been investigated at the molecular lev-
el in recent years (Moldoveanu et al., 2002). However,
after four decades of research, the mechanisms by which
calpain activity is spatially and temporally controlled at
the low Ca2q concentrations prevailing in resting or stim-
ulated cells (50–300 nM) remain enigmatic (Goll et al.,
2003). Although unautolysed calpain is evidently active
on protein substrates, autoproteolytic processing yields
an enzyme with trimmed 76-kDa L- and 18-kDa S-sub-
units and a reduced Ca2q requirement for enzymatic
activity. However, the Ca2q concentration required for
activity by the autolysed enzyme in vitro (0.5–2 mM for
mCP and 50–150 mM for mCP) is still far above the cel-
lular concentrations (Goll et al., 2003). The initial Ca2q
concentrations for autolysis in vitro are comparable to
those needed for proteolytic activity of the unautolysed
enzyme. Additional mechanisms have been proposed to
account for the reduction in activation threshold by Ca2q
in vivo: association with membrane phospholipids (Pon-
tremoli et al., 1985), activator molecules (Melloni et al.,
1998), phosphorylation by protein kinases (Glading et al.,
2004), and calpain activation cascades (Tompa et al.,
1996; Ono et al., 2004). The existing reports on how
these factors contribute to calpain activation are often
controversial and their modes of action remain largely
unexplored (Goll et al., 2003).
The putative role of membranes in calpain activation is
based on the in vitro observation that membrane phos-
pholipids reduce the Ca2q requirement for autolysis (Coo-
lican and Hathaway, 1984; Saido et al., 1992). Therefore,
the commonly accepted ‘membrane activation hypothe-
sis’ (Suzuki et al., 1987; Zalewska et al., 2004) emerged,
postulating that calpain is activated at the cellular mem-
branes, where the interaction with membranes somehow
increases its Ca2q sensitivity. Under resting conditions,
only small amounts of erythrocyte calpain have been
detected in the detergent-soluble fraction (Hatanaka
et al., 1984) and at cellular membranes in situ (Samis and
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Elce, 1989). Upon treatment with Ca2q ionophores, add-
ed amounts of m-calpain have been found associated
with the membrane fraction of lysed cells or located at
the cell periphery in situ (Saido et al., 1993; Gil-Parrado
et al., 2003). Recent work revealed an increased asso-
ciation of calpains with the endoplasmic reticulum and
the Golgi apparatus after stimulation of cells with laminin.
In these studies m-calpain co-localised with phosphati-
dylinositol-4,5-bisphosphate (PIP2) and with membrane
lipid rafts (Hood et al., 2004). However, Zalewska et al.
(2004) reported that inside-out erythrocyte vesicles did
not lower the Ca2q requirement for autolysis of m- and
m-calpain. To be activated by interaction with mem-
branes, the calpains should be able to bind to the mem-
branes at significantly lower Ca2qconcentrations than are
required for enzymatic activity. To date, in vitro data on
the Ca2q requirement for the binding of isolated calpains
to membranes and on their affinity for membranes are
lacking.
Owing to their structural features, domain V of the S-
subunit and the ‘C2-like’ domain III of the L-subunit are
favourite candidates for phospholipid binding sites in cal-
pains. Domain V is an unusual, hydrophobic, Gly-rich
sequence that did not diffract in X-ray crystallography
(Strobl et al., 2000). Studies with calpains lacking domain
V, as well as with synthetic peptides mimicking parts of
this domain, suggested a role of domain V in the inter-
action of calpain with membranes (Imajoh et al., 1986;
Crawford et al., 1990; Arthur and Crawford, 1996; Bran-
denburg et al., 2002; Dennison et al., 2005). Domain III
weakly resembles C2 domains, which are Ca2q- and
phospholipid-binding modules found in a number of sig-
nalling and membrane trafficking proteins (Rizo and Sud-
hof, 1998; Cho, 2001). In the ‘canonical’ C2 domains,
Ca2q is complexed by negatively charged side chains of
the b-strand interconnecting loops. Although these
motifs in domain III of calpains differ from the classical
C2 domains in sequence and topology, a cluster of acidic
residues, the so-called ‘acidic loop’, may have the poten-
tial to bind up to three Ca2q ions (Strobl et al., 2000).
Mutations within this ‘acidic loop’ have been shown to
strongly affect Ca2q-dependent activation of the calpains
(Alexa et al., 2004; Fernandez-Montalvan et al., 2004).
Recent work has demonstrated that recombinant domain
III of rat m-calpain and Drosophila calpain B can bind
Ca2q in a phospholipid-dependent manner and that this
Ca2q binding is abolished by deletion of the acidic loop
of domain III (Tompa et al., 2001; Alexa et al., 2004). In
cell culture experiments with overexpressed EYFP fusion
proteins, Gil-Parrado et al. (2003) provided evidence that
domain III is required for translocation of the large subunit
of mCP from the cytosol to the cell periphery.
Here we address some basic issues related to
membrane binding of m-calpain in a simplified in vitro
model. Active-site mutants of m-calpain were used that
do not hydrolyse substrates or autolyse (and subse-
quently inactivate) on Ca2qexposure, but undergo essen-
tially the same conformational changes as the non-
mutated enzyme (Fernandez-Montalvan et al., 2004). The
interaction of these recombinant proteins with free or
immobilised phospholipid vesicles was analysed by flu-
orescence resonance energy transfer (FRET) and surface
plasmon resonance (SPR) (Cho et al., 2001). We deter-
mined the Ca2q requirement and the affinity of binding to
free and immobilised liposomes of various compositions.
Moreover, mutated proteins were used to analyse the
contributions of domain V and of the acidic loop of
domain III to phospholipid binding, with the objective of
delineating a molecular mechanism for the interaction of
calpains with membrane lipids. We provide experimental
evidence supporting the novel hypothesis that in vitro
Ca2q-dependent binding of m-calpain to lipid bilayers is
mostly due to the increased hydrophobicity of the acti-
vated molecules and does not itself lower the Ca2q
demand for activation.
Results
Heterologous expression and purification of
functional m-calpain variants
In a recent communication we described the generation
and use of baculoviral vectors for the expression in Sf21
insect cells of full-length heterodimeric active and C115A
active-site mutated m-calpain and seven variants thereof
containing further point mutations within the acidic loop
of domain III (Fernandez-Montalvan et al., 2004). The
C115A variants are catalytically inactive and therefore not
prone to autolysis, but fully functional in terms of Ca2q-
dependent conformational changes and binding of cal-
pastatin. For the present study, C115A m-calpain and its
mutants D402A, E403A, D405A, D406A, D408A, D412A,
and E414A (Figure 1A) were expressed and purified using
the same methodology. The recombinant proteins were
obtained in high purity (Figure 1B).
In addition, we expressed a heterodimeric C115A m-
calpain in which the first 85 N-terminal residues of the
small subunit were deleted (Figure 1A). This variant,
Lq(DV)S, lacks domain V almost completely and its trun-
cated small subunit resembles the fragment resulting
from autoproteolytic cleavage of the natural enzyme
(Gabrijelcic-Geiger et al., 2001; Li et al., 2004). In contrast
to rat m-calpain expressed in E. coli (Elce et al., 1997),
replacement of the small subunit by its truncated form
did not improve the expression yields of the m-calpain
heterodimer in insect cells. Ca2q-dependent conforma-
tional changes detected by 2-p-toluidinylnaphthalene-6-
sulfonate (TNS) fluorescence indicate that (C115A)Lq
(DV)S is functional (Figure 1C).
For the first time we succeeded in expressing the sin-
gle full-length small subunit (28 kDa) of m-calpain in suf-
ficient quantities for functional characterisation. Western
blot analysis of the lysates indicated the expression of a
soluble protein of the expected molecular weight in the
insect cells. Microgram quantities of the isolated small
subunit were obtained after affinity purification on a cal-
pastatin BC-peptide (subdomains B and C of calpastatin
domain 1) column. SDS-PAGE of the purified protein
(Figure 1B) showed only minor contaminating bands.
Detection of Ca2q-dependent binding to immobilised cal-
pastatin domain 1 and to the calpastatin BC-peptide in
SPR experiments confirmed that the isolated recombi-
nant protein was properly folded and functional (Figure
1D). These features, however, deteriorated very rapidly
during storage. Therefore, experiments with this protein
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Figure 1 Design and functional integrity of the recombinant
calpain constructs.
(A) Schematic representation of the calpain constructs used in
this work: LqS, heterodimeric m-calpain composed of C115A
active site-mutated large (L) and full-length small (S) subunit;
Lq(DV)S, heterodimeric m-calpain comprising the C115A large
(L) and a truncated small subunit lacking residues 1–85 of
domain V; S, single full-length small subunit; (DV)S, single trun-
cated small subunit lacking residues 1–85. In addition, a series
of heterodimers containing acidic-loop single mutations of
(C115A)L were prepared as indicated above the bars. LqS,
Lq(DV)S and S were expressed in Sf21 insect cells using the
baculovirus system; (DV)S was expressed in E. coli. (B) SDS-
PAGE analysis of the calpain variants shown in panel A, purified
either on a BC-calpastatin or a Ni-NTA affinity column (seemate-
rials and methods). The upper bands represent the large (80 kDa)
and the lower the small (28 kDa or 21 kDa) subunits. (C) Ca2q
titration of LqS and Lq(DV)S monitored by TNS fluorescence
(see materials and methods). (D) Sensorgram showing the inter-
action of the S subunit with immobilised domain 1 (ABC) and a
fragment containing subdomains BqC (BC) of calpastatin at
0.5 mM free Ca2q. Immobilised chicken cystatin (CC), which
does not interact with calpain, was used as a control.
were performed shortly after elution from the affinity
column.
Bacterial expression of the single truncated small
subunit, (DV)S, of m-calpain (Figure 1A) and its isolation
by Ni-NTA affinity chromatography (Figure 1B) were per-
formed as previously described (Minami et al., 1987; Diaz
et al., 2001). The functional integrity of the protein iso-
lated was confirmed by measuring Ca2q-dependent
conformational changes using TNS fluorescence spec-
troscopy (data not shown) and binding to immobilised
calpastatin in SPR experiments as previously reported
(Diaz et al., 2001). Unlike the full-length small subunit, the
21-kDa protein conserved its functional properties during
long-term storage.
Membrane binding of m-calpain is Ca2H-dependent,
but lacks headgroup selectivity
Interaction of the recombinant calpain proteins with free
liposomes was studied by protein-to-lipid FRET meas-
urements with N-(5-dimethylaminonaphthalene-1-sulfo-
nyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanola-
mine (dansyl DHPE)-labelled small unilamellar vesicles
(Cho et al., 2001). To mimic more closely the lipid bilayer
of biological membranes, the vesicles were captured on
a Pioneer L1 sensor chip, where they fuse to form a lipid
bilayer (Erb et al., 2000). Binding of the proteins to the
immobilised lipid bilayers was analysed by SPR. With
both methods we observed Ca2q-dependent binding of
heterodimeric m-calpain to the model membranes (Figure
2A, B). As can be observed from the SPR sensorgrams
in Figure 2B, binding was quickly reversed when Ca2q
was washed out using a Ca2q-free running buffer. In the
presence of a saturating Ca2q concentration (1 mM), con-
centration-dependent binding of mCP was observed
(Figure 2C). By fitting the data to a 1:1 Langmuir binding
model, association (ka) and dissociation (kd) rate con-
stants were determined separately from the association
and dissociation phases of the sensorgrams. The equilib-
rium dissociation constants (Kdskd/ka) calculated from
these rate constants were in the nanomolar range (Table
1).
The SPR experiments were repeated with captured
liposomes of various composition, representing different
ratios of zwitterionic and anionic head groups, as well as
mimicking typical plasma and nuclear envelope mem-
branes (Stahelin et al., 2003) (Table 1). Furthermore, in
some liposomes, PI, PIP and PIP2 (see materials and
methods for abbreviations) were included. As shown in
Table 1, the lipid composition of the vesicles had no sig-
nificant influence on the binding affinity (Kd). This lack of
headgroup selectivity was unexpected on the basis of (i)
previous papers reporting that PIP2, and to a lesser
extent PI, were more effective than other phospholipids
in lowering the Ca2q concentration required for proteo-
lytic activity of m-calpain (Saido et al., 1991, 1992); and
(ii) published results on Ca2q-dependent membrane bind-
ing of C2 domains indicating a clear preference for either
anionic (e.g., PS) or zwitterionic (e.g., PC) lipids (Stahelin
et al., 2003).
Membrane binding has a similar Ca2H requirement
as TNS binding and enzymatic activity in the
absence of lipids
The free calcium concentration for half-maximal mem-
brane binding, wCa2qx0.5, was determined in Ca2q titration
experiments monitored by protein-to-lipid FRET meas-
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Figure 2 Ca2q-dependent interaction of m-calpain with liposomes.
(A) Spectra recorded at 280 nm excitation showing fluorescence resonance energy transfer (FRET) from LqS-mCP to dansyl-DHPE
labelled PC/PG (70:30) liposomes in the absence and in the presence of 1 mM CaCl2. (B) Representative Biacore sensorgrams
recorded at increasing Ca2q concentrations (as indicated) after injection of 50 nM LqS-mCP to a Pioneer L1 sensor chip coated with
plasma membrane-mimicking vesicles (see Table 1). (C) Representative sensorgrams recorded at 1 mM CaCl2 after injection of
increasing concentrations of LqS-mCP (as indicated) to an identical chip as in panel (B). For composition of the running buffer and
conditions for data collection, see the materials and methods section. Solid lines, experimental data; dashed lines, data globally fitted
to a 1:1 interaction model, as described in materials and methods. (D) Semilogarithmic Ca2q titration curves for peptidolytic activity
(active recombinant mCP), TNS fluorescence (LqS-mCP), protein-to-liposome FRET (LqS-mCP) and SPR-monitored binding to immo-
bilised liposomes (LqS-mCP). The different effects were normalised and fitted with the Hill equation as described in materials and
methods (lines). Data for activity and TNS fluorescence are from Fernandez-Montalvan et al. (2004).
Table 1 Ca2q requirement and kinetic constants for membrane binding of human (C115A)LqS m-calpain
determined from SPR analysisa.
Lipid vesiclesb wCa2qx0.5 Hill ka (M-1s-1) kd (s-1) Kd (nM)
(mM) coefficientc
PC/PE (60:40) 125"19 1.7"0.4 (1.4"0.2)=105 (3.1"0.3)=10-4 2.2"0.4
PC/PS (60:40) 117"17 1.8"0.4 (1.2"0.1)=105 (2.8"0.2)=10-4 2.3"0.3
PC/PG (60:40) 135"20 1.6"0.3 (1.4"0.2)=105 (4.1"0.4)=10-4 2.9"0.5
PC (100) 106"16 1.9"0.5 (1.6"0.1)=105 (4.0"0.5)=10-4 2.5"0.3
PC/PE/PS (60:20:20) 111"5.7 2.3"0.2 (1.7"0.2)=105 (3.2"0.3)=10-4 1.9"0.3
PC/PE/PS/PI (60:20:18:2) 115"6.3 2.3"0.3 (1.5"0.2)=105 (3.0"0.6)=10-4 2.0"0.5
PC/PE/PS/PIP (60:20:18:2) 109"5.7 2.2"0.2 (1.6"0.3)=105 (3.9"0.7)=10-4 2.4"0.6
PC/PE/PS/PIP2 (60:20:18:2) 108"5.3 2.2"0.2 (1.6"0.2)=105 (4.2"0.8)=10-4 2.6"0.4
Plasma membrane mimicd 99"2.5 2.2"0.3 (1.4"0.2)=105 (2.2"0.3)=10-4 1.6"0.3
Nuclear envelope mimice 111"8.8 1.8"0.1 (1.6"0.2)=105 (2.7"0.3)=10-4 1.7"0.3
aValues represent the mean"SD from two to three different estimations, each comprising six to ten different
concentrations.
bSee the materials and methods section for explanation of the abbreviations.
cHill coefficient for Ca2q-dependent binding.
dPC/PE/PS/PI/cholesterol (12:35:22:9:22).
ePC/PE/PS/PI/cholesterol (61:21:4:7:7).
urement and/or SPR. The mean wCa2qx0.5 for the associ-
ation of heterodimeric full-length C115A m-calpain with
membranes composed of PC/PG was 97.1"1.5 mM
when determined by FRET assay (PC/GGs70:30) and
135"20 mM by SPR measurements (PC/PGs60:40). Like
the Kd values, wCa2qx0.5 values were not significantly dif-
ferent for membranes of different lipid composition (Table
1). Hill coefficients (Weiss, 1997) in the region of 2 indi-
cated positive cooperativity (see the discussion section).
Unexpectedly, the wCa2qx0.5 values for membrane bind-
ing were very similar to the corresponding values that we
had previously determined for Ca2q-induced conforma-
tional changes of C115A m-calpain, probed by TNS flu-
orescence, and for enzymatic activity of active m-calpain
Membrane binding of m-calpain 621
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Table 2 Ca2q requirement for half-maximal membrane
binding of domain III acidic loop mutants of (C115A)LqS
m-CP determined by protein-to-lipid FRET.
wCa2qx0.5 (mM)
FRETa TNSb Activityb
LqS 97.1"1.5 130.6"3.8 104.4"4.9
(D402A)LqS 50.9"1.5 82.8"2.7 44.9"3.4
(E403A)LqS 29.4"2.5 66.7"2.5 34.9"2.0
(D405A)LqS 41.5"0.6 31.7"3.0 15.2"1.1
(D406A)LqS 43.8"1.2 57.7"2.1 24.0"1.5
(D408A)LqS 58.1"2.1 73.5"5.6 34.1"0.9
(D412A)LqS 58.1"2.6 93.0"4.1 46.7"1.1
(E414A)LqS 50.1"2.1 86.5"3.1 48.1"2.0
awCa2qx0.5 from the data shown in Figure 3 obtained with
POPC/POPG (70:30) vesicles supplemented with 5%
dansyl-DHPE.
bwCa2qx0.5 values for TNS binding of (C115A)LqSmCP and
peptidolytic activity of LqS m-CP were taken from Fer-
nandez-Montalvan et al. (2004).
Figure 3 Effect of acidic loop mutations on Ca2q-dependent
interaction with liposomes.
Ca2q titration of FRET from LqS-mCP and seven acidic loop
mutants (as indicated) to dansyl-DHPE labelled PC/PG (70:30)
vesicles. The FRET signals were normalised for comparison and
fitted with the Hill equation (lines). Results are listed in Table 2.
in the absence of lipids (Fernandez-Montalvan et al.,
2004). Almost coincident Ca2q titration curves were
obtained for membrane binding and these effects (Figure
2D), suggesting that in vitro activation by calcium ions
and membrane binding are closely linked processes.
Attempts to measure calpain binding to liposomes at
physiological cellular Ca2q concentrations (below 1 mM)
were not successful because of methodological limita-
tions imposed by undetectably low signals in FRET and
non-compensatable unspecific binding in SPR experi-
ments of high sensitivity.
Acidic loop mutations in domain III lower the Ca2H
requirement for membrane binding, but do not
affect membrane affinity
From the reported ability of the acidic loop of isolated
domain III to bind Ca2q in a lipid-dependent manner
(Alexa et al., 2004), a significant role of this region in the
Ca2q-dependent interaction of the calpain heterodimer
with membrane lipids could be anticipated. It has been
reported that mutations within the binding loops of C2
domains affect binding to lipid vesicles and subcellular
targeting in living cells (Stahelin et al., 2003). In previous
work we performed an Ala-scan of the acidic residues in
the acidic loop of C115A m-calpain (Fernandez-Montal-
van et al., 2004). Here we determined the Ca2q require-
ment for membrane binding of these mutants by
protein-to-lipid FRET (Figure 3, Table 2). Unexpectedly,
abrogation of single potential Ca2q coordination sites
within the acidic loop did not increase the Ca2q require-
ment, but even resulted in two- to three-fold lower
wCa2qx0.5 values for membrane binding (Table 2). Accord-
ingly, a 2.5-fold lower wCa2qx0.5 for membrane binding of
D405A C115A-mCP was found in SPR experiments.
The reduced wCa2qx0.5 values for vesicle binding of the
mutants correlate with reduced wCa2qx0.5 values for con-
formational changes probed by TNS binding and for
enzymatic activity, which we observed in the absence of
lipids (Table 2). We explain the increased calcium sensi-
tivity of these mutants by weakened electrostatic inter-
actions of the acidic loop, facilitating the conformational
changes required for activation (Fernandez-Montalvan et
al., 2004). In SPR experiments, the D405A mutant
(D405A)LqS had similar phospholipid affinity as the
‘wild-type’ LqS and also lacked headgroup selectivity
(Table 3).
Deletion of domain V lowers the membrane affinity
of the heterodimer
Deletion of domain V, leading to the Lq(DV)S heterodi-
mer, resulted in 10- to 15-fold reduced membrane bind-
ing affinity measured in SPR experiments (Figure 4A,
Table 3). No significant effects on headgroup selectivity
were observed. Previous reports (Imajoh et al., 1986;
Crawford et al., 1990; Arthur and Crawford, 1996) sug-
gesting a role for domain V in the interaction of the cal-
pains with membranes were confirmed and extended
by our quantitative data. Interestingly, even for the
(D405A)Lq(DV)S variant, in which the contribution of
domain V is eliminated, the additional acidic loop D405A
mutation had no significant effect on lipid binding affinity
(Table 3).
Membrane affinity of the single small subunit
strongly depends on the presence of domain V
To further investigate the role of domain V in membrane
binding, we analysed the interaction with captured lipo-
somes of the single full-length small subunit, S, and of
a truncated mutant thereof lacking residues 1–85 of
domain V, (DV)S. Surprisingly, the Ca2q-dependent asso-
ciation of the full-length small subunit alone with immo-
bilised phospholipid bilayers in SPR experiments (Figure
4B) was only four- to eight-fold lower than the membrane
affinity of the LqS heterodimer (Table 3). However,
removal of domain V from the single small subunit, lead-
ing to the (DV)S variant, resulted in a 600-fold reduced
Ca2q-dependent affinity for immobilised bilayers when
compared with the full-length small subunit (Figure 4C,
Table 3).
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Table 3 Membrane binding parameters for calpain variants determined from SPR analysisa.
Lipid vesiclesb ka (M-1 s-1) kd (s-1) Kd (nM) Fold increase in Kdc
(D405A)LqS PC/PE (1.1"0.1)=105 (3.0"0.6)=10-4 2.7"0.6 1.2
PC/PS (1.1"0.1)=105 (2.7"0.7)=10-4 2.5"0.7 1.1
PC/PG (1.0"0.1)=105 (3.3"0.7)=10-4 3.3"0.8 1.1
PC (1.1"0.2)=105 (4.2"0.6)=10-4 3.8"0.9 1.5
Lq(DV)S PC/PE (3.1"0.9)=103 (1.1"0.2)=10-4 35.5"12.2 16
PC/PS (3.5"0.5)=103 (1.1"0.1)=10-4 31.4"5.3 14
PC/PG (4.0"1.0)=103 (1.4"0.3)=10-4 35.0"11.5 12
(D405A)Lq(DV)S PC/PE (3.2"0.3)=103 (1.1"0.1)=10-4 34.4"4.5 16
PC/PS (3.7"0.1)=103 (1.1"0.2)=10-4 29.7"5.5 13
S PC/PE (6.5"0.2)=103 (1.1"0.4)=10-4 16.9"6.2 7.7
PC/PS (8.4"0.5)=103 (1.5"0.5)=10-4 17.9"6.1 7.8
PC/PG (1.3"0.4)=104 (1.6"0.3)=10-4 12.3"4.4 4.2
PC (1.4"0.4)=104 (1.6"0.4)=10-4 11.4"4.3 4.6
(DV)S PC/PE (7.0"0.1)=102 (6.1"1.0)=10-3 8700"1430 4000
PC/PS (5.5"1.5)=102 (6.2"1.1)=10-3 11300"3700 4900
PC/PG (4.5"0.4)=102 (3.2"0.4)=10-3 7100"1090 2500
aValues represent the mean"SD from two to three different estimations, each comprising six to ten different
concentrations.
bSee Table 1 for lipid composition and the materials and methods section for explanation of the abbreviations.
cRelative to the binding of (C115A)LqS m-calpain shown in Table 1.
Discussion
In vitro membrane binding is due to increased
hydrophobicity of the activated calpain
Using two distinct biophysical methods, we determined
congruent wCa2qx0.5 values for Ca2q-dependent binding of
m-calpain to lipid bilayers in vitro. Our data reveal the
surprising fact that the association of C115A mCP with
phospholipid vesicles requires a similar non-physiologi-
cally high Ca2q concentration as unautolysed mCP for
enzymatic activity in the absence of lipids (see Figure
2D). These in vitro findings question a major premise of
the popular ‘membrane activation hypothesis’. According
to this hypothesis, significant membrane binding should
be observable at much lower Ca2q concentrations than
required for activation/autolysis in the absence of lipids
(see the introduction section). However, because of
methodological limitations (see the results section) we
cannot directly exclude a small amount of binding at Ca2q
concentrations below 1 mM that might be relevant to the
interaction of calpain with membranes in vivo.
When our in vitro results are applied to living cells, only
a very small proportion of calpain molecules (less than
1%) would be active and able to bind to the lipids of
cellular membranes. This scenario can principally explain
the rather low quantities of calpain found to be associ-
ated with cellular membranes under ‘resting conditions’
and the added membrane-associated localisation of cal-
pain after activation by moderately increased Ca2q levels
due to physiological stimuli or Ca2q ionophores (see
introduction). As active calpain is required for autolysis,
selective binding of the active conformation to mem-
branes would also explain the observed prevalence of
autolysed calpains at the plasma membrane (Anagli
et al., 1993).
We noted a close correlation between the Ca2q titration
curves for membrane binding and those for TNS fluores-
cence (see Figure 2D and Table 2). The increase in TNS
fluorescence is a well-established indicator for the expo-
sure of hydrophobic regions on proteins (Brand and
Gohlke, 1972) and has been observed previously with
calpain (Hong et al., 1990). Thus, we argue that the expo-
sure of a hydrophobic surface after calpain transition to
its active conformation (Pal et al., 2001; Dainese et al.,
2002; Li et al., 2004) should be responsible for the Ca2q-
dependent membrane binding in our experiments. This
type of membrane binding would occur simultaneously
with or shortly after activation. A close connection be-
tween activation and membrane binding is corroborated
by the Ca2q requirement for vesicle binding of a set of
domain III acidic-loop point mutants, which were previ-
ously shown to have up to seven-fold increased Ca2q
sensitivity for activation due to the disruption of electro-
static interactions of the acidic loop (Fernandez-Montal-
van et al., 2004). The wCa2qx0.5 values for phospholipid
binding of the corresponding active-site mutants are sim-
ilar to those measured previously for enzyme activity in
the absence of lipids (see Figure 2D and Table 2). Nota-
bly, the Hill coefficients for the Ca2q dependence of both
processes were also not significantly different, e.g., 2.8
for lipid binding of (C115A)LqS m-CP (determined by
FRET) and 2.4 for enzyme activity of LqS m-CP (Fernan-
dez-Montalvan et al., 2004). This is illustrated by almost
identical shapes of the Ca2q titration curves (Figure 2D).
As expected from previous work (Dutt et al., 2000; Mol-
doveanu et al., 2004), activation by Ca2q is positively
cooperative, but this cooperativity is likely not enhanced
by the presence of lipids.
Our data are in line with earlier results questioning the
role of membrane phospholipids in calpain activation
(Cong et al., 1989) and with the recently reported inability
of inside-out erythrocyte membranes to decrease the
Ca2q requirement for calpain autolysis (Zalewska et al.,
2004). In fact, we observed no consistent effects on the
Ca2q requirement for hydrolysis of the substrate Suc-LY-
AMC by human erythrocyte calpain when we added the
same phospholipid vesicles as used in the membrane
binding studies (data not shown). We explain the effects
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Figure 4 Effect of domain V deletion on membrane binding.
Representative sensorgrams recorded at 1 mM Ca2q for the
interaction of Lq(DV)S-mCP heterodimer (A), single S subunit (B)
and single (DV)S subunit (C) with PC/PS (60:40) liposomes coat-
ed on a Pioneer L1 sensor chip. See Figure 1A for the design of
the analytes. Solid lines, experimental data; dashed lines, data
globally fitted to a 1:1 interaction model, as described in the
materials and methods section.
of phospholipid vesicles on the Ca2q requirement for cal-
pain autolysis and activity that have been reported in
numerous studies (see Goll et al., 2003, and Zalewska
et al., 2004, for references) by hydrocarbon chain-medi-
ated stabilisation of the hydrophobic Ca2q-activated cal-
pain structure. This would increase the effective
concentration of active molecules able to activate more
molecules by (intermolecular) autoproteolysis and would
reduce the formation of inactive large protein aggregates
(Li et al., 2004). Interestingly, we have observed a stabi-
lising effect of non-ionic detergents such as Triton X-100
and Brij-35 on the Ca2q-dependent peptidolytic activity
of erythrocyte m-calpain (data not shown).
Interaction of calpain with membrane lipids is non-
selective
For the first time we obtained quantitative data on the
binding affinity of a calpain to lipid bilayers captured on
a L1 sensor chip (Tables 1 and 3). The dissociation con-
stants (Kd) were within the nanomolar range and are
therefore similar to those for other Ca2q-dependent
membrane binding proteins such as annexins (Tait et al.,
1989) and typical C2 domain-containing proteins, such
as PKC (Bazzi and Nelsestuen, 1987), synaptotagmin
(Niinobe et al., 1994) and phospholipase A2 (Kim et al.,
1997). This observation underlines the role of phospho-
lipids as potential binding partners of activated calpain
at the cellular membranes, a function once attributed
exclusively to membrane-associated proteins (Inomata
et al., 1990).
Interestingly, m-calpain showed no preference for neg-
atively charged phospholipid headgroups (as described
for most of the annexins and many C2 domain proteins,
which preferentially bind phosphatidyl serine), nor for
neutral/zwitterionic groups (as in the case of cPLA) (Cho,
2001; Gerke and Moss, 2002; Murray and Honig, 2002).
Unlike C2 domain-containing proteins, such as the
tumour supressor PTEN (Das et al., 2003), the binding
affinities of m-calpain to nuclear envelope and plasma
membrane-mimicking bilayers (Stahelin et al., 2003) were
similar, and the affinity was not changed by inclusion of
2% PIP2 in the liposomes. The lack of headgroup selec-
tivity supports a membrane-binding mechanism involving
hydrophobic interactions with the non-polar moieties of
phospholipid vesicles. Indeed, recent work using velocity
gradient centrifugation suggested that the large and
small subunits of m- and m-calpain may be embedded
within the organelle membranes, similar to integral
membrane proteins (Hood et al., 2004).
Lipid-binding sites of m-calpain: roles of domain V
and the ‘C2-like’ domain III
We have analysed for the first time the individual contri-
butions of the two putative lipid-binding sites, domain V
and domain III, in the context of a ‘stable’, non-autolysing
active-site mutated heterodimeric m-calpain.
A role for the hydrophobic Gly-rich domain V in
membrane binding seems likely owing to the 10- to 15-
fold reduction in the affinity for phospholipid vesicles we
observed with heterodimeric mCP lacking domain V. This
is strongly supported by our novel binding data for the
single small subunit. Ca2q-dependent binding of the full-
length small subunit to phospholipids had only a four- to
eight-fold lower affinity than the Ca2q-dependent binding
of the heterodimer to phospholipids (Table 3). These in
vitro results are consistent with our previous observation
of the Ca2q-dependent translocation of an overexpressed
small subunit to cellular membranes (Gil-Parrado et al.,
2003) and the recently reported association of the small
subunit with the endoplasmic reticulum and the Golgi
apparatus (Hood et al., 2004). The ;600-fold reduced
phospholipid affinity of the N-terminally truncated single
small subunit, (DV)S, clearly underlines the essential con-
tribution of domain V to lipid binding of the small subunit.
It should be noted that our (DV)S mutant lacks the
56GTAMRILGGVI66 sequence that has been implicated in
lipid binding of calpain (Arthur and Crawford, 1996; Bran-
denburg et al., 2002).
The small calpain subunit is a member of the penta-
EF-hand (PEF) protein family and, within this family, is
most similar to sorcin and grancalcin (Maki et al., 2002).
Typical PEF proteins are composed of a Ca2q-binding EF-
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hand domain corresponding to domains VI and IV of cal-
pain, and a Pro/Gly-rich N-terminal domain of variable
length, corresponding to domain V of calpain. Domain V
of calpain is significantly different from the N-terminal
extensions of all other PEF proteins because of its out-
standing length and peculiar sequence. A common fea-
ture of non-calpain PEF proteins is their Ca2q-induced
translocation from the cytosol to membranes, where they
interact with different target proteins. Depending on the
protein targets, Ca2q-dependent interactions can occur
either through the Ca2q-binding domains or, induced by
Ca2q binding to these domains, through the hydrophobic
N-terminal extension (see Maki et al., 2002, for a review).
To date, little is known about the interaction of non-cal-
pain PEF proteins with phospholipids, but recently a
Ca2q-dependent increase in hydrophobicity was reported
for a PEF protein from maize lacking an N-terminal exten-
sion (Barry et al., 2006). This is consistent with our results
showing that the truncated small subunit still binds to
liposomes in a Ca2q-dependent manner, although with
greatly reduced affinity.
In SPR experiments, wCa2qx0.5 for membrane binding of
the Lq(DV)S heterodimer was approximately two-fold
lower when compared to the LqS heterodimer containing
the full-length small subunit. This correlates with the
three-fold reduced wCa2qx0.5 for TNS fluorescence (Figure
1C) and eight-fold lower wCa2qx0.5 for enzyme activity of
non-active-site mutated Lq(DV)S m-calpain in the
absence of lipid vesicles (data not shown), suggesting a
role for domain V in the activation process.
The only 10- to 15-fold reduction in membrane affinity
by truncation of domain V within the heterodimer points
to an almost equally important contribution of the large
subunit to lipid binding. The regions of the large subunit
involved in membrane binding are not known. Surpris-
ingly, the domain III acidic-loop D405A mutants with and
without domain V bind to immobilised vesicles with sim-
ilar affinity as the corresponding non-mutated enzymes
(Table 3). As expected from structural and functional
data, the D405A point mutation should disrupt the most
important residue in a putative Ca2q/phospholipid nucle-
ation site of the ‘C2-like’ domain III (Strobl et al., 2000;
Alexa et al., 2004). A number of site-directed mutage-
nesis studies with the C2 domains of PKCa (Bolsover et
al., 2003), cPLA (Bittova et al., 1999), synaptotagmin
(Fernandez-Chacon et al., 2002) and other C2 domain
proteins have shown that neutralising mutations of the
acidic residues in the Ca2q-binding loops of C2 domains
usually result in an important loss of affinity for mem-
brane lipids. Our data suggest that the contribution of
the single acidic-loop residue mutated here is minimal in
the context of a heterodimeric calpain.
Conclusions
Ca2q-dependent binding of recombinant m-calpain to the
model membranes studied in this work seems to be due
to the exposure of a hydrophobic surface upon activa-
tion, and thus exhibits a similar Ca2q requirement as the
activation process in the absence of lipids in vitro. It
remains open to what extent these findings are relevant
in vivo, because the Ca2q concentrations used in our
experiments were far above the physiological Ca2q levels
that have been shown to activate calpain in cells (Mat-
sumura et al., 2001). However, Friedrich (2004) recently
argued that ‘the unphysiologically high Ca2q demand for
activation may turn out to be an evolutionary adjusted
safety device’, and the local activation of only a small
portion of total calpain ‘working at the initial, ascending
limb of its Ca2q saturation curve’ would meet best its
roles in signal transduction. We hypothesise that binding
of calpain to membrane lipids during or after activation
may be a biologically relevant mechanism that helps to
‘concentrate’ and stabilise the few active molecules, thus
enabling them to cleave substrates associated with the
plasma membrane or membranes of subcellular organ-
elles. Hitherto not well understood mechanisms, such as
phosphorylation of the calpains by membrane-associat-
ed protein kinases and/or interactions with membrane
proteins, may lower the Ca2q demand for activation and
locally increase the number of active molecules binding
to and acting at the cellular membranes.
Materials and methods
Materials
Expand High Fidelity DNA polymerase, restriction endonu-
cleases and other DNA modifying enzymes were purchased
from Roche (Mannheim, Germany). Oligonucleotides were syn-
thesised by Roth (Freiburg, Germany). Protocols, media and
reagents for heterologous protein expression in Spodoptera fru-
giperda (Sf) insect cells using the baculovirus system were from
Pharmingen (BD Biosciences, Heidelberg, Germany) and Invitro-
gen (Groningen, The Netherlands). Heterodimeric full-length
C115A m-calpain variants were expressed and purified as pre-
viously described (Fernandez-Montalvan et al., 2004). 2-p-Tolui-
dinylnaphthalene-6-sulfonate (TNS) and N-(5-dimethylamino-
naphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phos-
phoethanolamine (dansyl-DHPE) were purchased from Molecu-
lar Probes (Leiden, The Netherlands). 1-Palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (PC), 1-palmitoyl-2-oleoyl-sn-gly-
cero-3-phosphoethanolamine (PE), 1-palmitoyl-2-oleoyl-sn-
glyce-ro-3-wphospho-L-serinex (PS), 1-palmitoyl-2-oleoyl-sn-
glycero-3-wphospho-rac-(1-glycerol)x (PG), L-a-phosphatidylino-
sitol (PI), L-a-phosphatidylinositol-4-phosphate (PIP), L-a-phos-
phatidylinositol-4,5-bisphosphate (PIP2) and cholesterol were
obtained from Avanti Polar Lipids (Alabaster, AL, USA). CM5 and
L-1 Pioneer sensor chips and other SPR-related reagents were
purchased from Biacore (Uppsala, Sweden). Reagent-grade
chemicals were obtained from Merck (Darmstadt, Germany) or
Sigma-Aldrich (Taufkirchen, Germany) unless otherwise
indicated.
Expression and purification of LHDVS m-calpain
The N-terminally truncated small subunit (D1–85)S of human cal-
pain had been previously cloned in the pET-22b(q) vector with
a C-terminal hexahistidine (His6) tag for bacterial expression
(Diaz et al., 2001). For expression in insect cells, the sequence
was subcloned into the baculovirus transfer plasmid pVL1392
by double digestion with XbaI/BamHI and subsequent ligation.
Generation of a recombinant AcNPV-hCAPN4-(D1–85)S-His6
baculovirus expressing the truncated small subunit was per-
formed as described for the full-length variant (Fernandez-Mon-
talvan et al., 2004). Production of the heterodimeric Lq(DV)S
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m-calpain was achieved by co-infection of Sf21 cells with this
new viral vector and the vector coding for the 80-kDa L subunit,
AcNPV-hCAPN1-80K(C115A), as previously reported (Fernan-
dez-Montalvan et al., 2004). Heterologous expression was fol-
lowed by one-step purification on a calpastatin BC-peptide
(subdomains BqC of calpastatin domain 1) affinity column as
previously described (Fernandez-Montalvan et al., 2004).
Expression and purification of m-calpain small-
subunit variants
To produce the full-length small subunit (S, 28K), Sf21 insect
cells were infected with the AcNPV-hCANPN4-28K viral vector
described by Fernandez-Montalvan et al. (2004) at an MOI (mul-
tiplicity of infection) of 1. Protein purification was performed on
the BC-calpastatin affinity column using the same protocol as
for the heterodimeric molecule. Bacterial expression induced by
isopropylthiogalactoside (IPTG) and affinity purification of the
truncated (D1–85)S small subunit (21K) on a Ni-NTA column
were performed as described by Diaz et al. (2001).
Ca2H-dependent changes in TNS fluorescence
TNS fluorescence probing Ca2q-dependent conformational
changes of the heterodimeric LqS m-calpain variants wasmeas-
ured as previously described (Fernandez-Montalvan et al., 2004).
Preparation of liposome vesicles
Phospholipids were purchased in their powder form and resus-
pended in chloroform to create stock solutions of defined con-
centrations. After mixing different species in the desired molar
ratios (as listed below under FRET and SPR measurements) to
a total concentration of 10 mM, chloroform was evaporated from
the samples under a stream of nitrogen. The mixtures were fur-
ther desiccated for 2 h and the resulting lipid film was resus-
pended in the appropriate assay buffer by vigorous vortexing.
The vesicles were downsized to small unilamellar vesicles of uni-
form size using a LiposoFast mini-extruder (Avestin Inc., Otta-
wa, Canada) equipped with 50-nM polycarbonate membranes
following the manufacturer’s guidelines.
Ca2H-induced protein-to-lipid FRET
Binding of (C115A) m-calpain variants to dansyl-labelled lipo-
somes was studied using the method described by Nalefski and
Falke (2002). Different dansyl-labelled small unilamellar vesicles
containing PC/PE, PC/PS, PC/PG or PC/PI in a molar ratio of
70:30 supplemented with 5% dansyl-DHPE were prepared in a
buffer containing 50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA and
5 mM 2-mercaptoethanol. FRET measurements (excitation at
280 nm) were performed in this buffer with and without CaCl2 at
228C in a Spex FluoroMax fluorescence spectrophotometer
(Jobin Yvon, Edison, NJ, USA) equipped with a stirrer-adapted,
temperature-controlled cuvette holder set. Ten mM of dansyl-
labelled vesicles were mixed with 0.1 mM protein solution (based
on absorbance at 280 nm) to a final volume of 3 ml. Small ali-
quots of a CaCl2 stock solution were added to the continuously
stirred reaction volume every 2 min and the fluorescence inten-
sity was recorded after 1.5-min incubation until saturation was
reached. The increment in reaction volume was kept to-1% of
the total. Control measurements were performed with MgCl2
instead of CaCl2. The normalised fluorescence intensity data
(emission at 510 nm) were fitted to a modified Hill equation
ysF0qFm=wxn/(xnqwCa2qx0.5n)x, where y is the fraction of maxi-
mum protein-to-membrane FRET, F0 represents the protein-
to-lipid FRET in the absence of Ca2q, Fm is the maximum
protein-to-lipid FRET achieved by Ca2q saturation, x is the actu-
al free Ca2q concentration (mM), n is the Hill coefficient (Weiss,
1997), and wCa2qx0.5 represents the calcium concentration for
half-maximal protein-to-lipid FRET.
Surface plasmon resonance (SPR) measurements
SPR sensorgrams were collected using a Biacore 2000 instru-
ment. CM5 chips were activated as described by Diaz et al.
(2001) and recombinant calpastatin domain 1 (ABC), a fragment
containing subdomains BqC (BC) (Fernandez-Montalvan et al.,
2004) and chicken cystatin (CC) as control were immobilised via
amine groups. Binding experiments with full-length S subunit,
(DV)S subunit, and heterodimeric LqS m-calpain variants were
performed in 50 mM Tris/HCl, pH 7.5, 100 mM NaCl, 0.015%
Brij-35, with or without 1 mM free Ca2q at a flow rate of 20
ml/min. After each experiment the surface was regenerated with
10 ml of 3 M guanidine hydrochloride, pH 6.5.
Small unilamellar vesicles for SPR measurements (10 mM)
were prepared in running buffer (10 mM Tris/HCl, pH 7.5,
150 mM NaCl) as described above with the various different lipid
compositions listed in Table 1. Pioneer L1 sensor chips were
coated with 30 ml of a 0.1 mM liposome suspension (2 ml/min)
followed by several washing steps with 50 ml of 50 mM NaOH
(100 ml/min). Interaction experiments were performed at 20
ml/min. Initially, a 4-min pulse of 0.05–1 mM of C115A m-calpain
variant or small subunit (1 mM CaCl2) was injected, followed by
intensive washes with regeneration solutions (see below) to
block residual unspecific binding.
For Ca2q titration experiments, solutions of the calpain vari-
ants in non-saturating concentrations w20–50 nM for full-length
heterodimer, 100–200 nM for Lq(DV)S heterodimer or small
subunit, all based on 280-nm absorbancex were adjusted to
increasing free Ca2q concentrations between 0 and 2 mM imme-
diately before sample injection. After injection, the association
phase was monitored over 4 min, followed by a dissociation of
8 min. At the end of the interaction experiment, the immobilised
vesicles were washed at 100 ml/min with two consecutive 2-min
pulses of 100 mM EDTA and 50 mM NaOH. After each set of
experiments, the lipids were removed from all four flowcells by
injection of 10 ml of 40 mM octyl glycoside and/or 10 ml of
20 mM CHAPS (3-w(3-cholamidopropyl)dimethylammoniox-1-
propanesulfonate) at 20 ml/min, and the L1-chip was coated
with fresh vesicle solution. For evaluation, the increase in reso-
nance units (RU) during the nearly linear initial phase of asso-
ciation (0.1–1 or 0.1–2 min) was plotted against the free
Ca2q concentration and fitted to a modified Hill equation:
ysR0qRm=wxn/(xnqwCa2qx0.5n)x, where R0 is the response at
wCa2qxs0, Rm is the maximum response achieved by Ca2q sat-
uration, x is the free Ca2q concentration (mM), n is the Hill co-
efficient, and wCa2qx0.5 is the calcium concentration for
half-maximal binding (mM).
To analyse the membrane binding kinetics of calpain variants,
Pioneer L1 sensor chips were coated and pretreated as
described above. The running buffer (20 ml/min) was the same
as before but supplemented with 1 mM CaCl2. Solutions con-
taining seven to ten increasing concentrations (based on 280-
nm absorbance) of the calpain variants w0.001–0.1 mM of the
full-length heterodimeric variants, 0.01–0.700mM of the Lq(DV)S
heterodimeric variants or of the small subunit, 1–20 mM of the
truncated (DV)S subunitx were injected in running buffer contain-
ing 1 mM free Ca2q. Association was followed over 4 min and
dissociation over 12 min. The membranes were regenerated as
described above after each set of variant injections. A control
lane loaded with aged vesicles of PC/PG (60:40) or PC, which
showed virtually no protein binding, was subtracted to correct
for bulk effects of buffer and/or sample and for non-specific
binding. Association and dissociation phases of all sensorgrams
were globally fitted to a 1:1 Langmuir binding model (pro-
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teinqprotein-binding site on the vesiclelcomplex) using the
Biaevaluation 3.0 software (Biacore). The dissociation phasewas
analysed using the equation:
RsR0e-kd (t-t0)
where kd is the dissociation rate constant (s-1) and R0 is the initial
response. The association phase was evaluated using the
equation:
-(k Cqk )(t-t )a d 0Rswk C/(k Cqk )xR w1-e xqRIa a d max
where Rmax is the maximum analyte binding capacity, C is the
analyte concentration, ka is the association rate constant (M-1
s-1), kd is the dissociation rate constant, set to the value obtained
from the dissociation phase, t0 is the start time for the data fit-
ting, and RI is the change in refractive index of the bulk. The
equilibrium dissociation constant (Kd) was then calculated as
Kdskd/ka.
Acknowledgements
Heide Hinz, Barbara Meisel and Rita Zauner are gratefully
acknowledged for their outstanding technical assistance. We
thank Dr. Shirley Gil-Parrado for stimulating discussions and
Prof. Wolfram Bode for generous support. This work was sup-
ported by the Sonderforschungsbereich 469 of the Ludwig-
Maximilians University of Munich (grants A3 and A6 to W.M.).
References
Alexa, A., Bozoky, Z., Farkas, A., Tompa, P., and Friedrich, P.
(2004). Contribution of distinct structural elements to
activation of calpain by Ca2q ions. J. Biol. Chem. 279,
20118–20126.
Anagli, J., Hagmann, J., and Shaw, E. (1993). Affinity labelling of
the Ca2q-activated neutral proteinase (calpain) in intact
human platelets. Biochem. J. 289, 93–99.
Arthur, J.S. and Crawford, C. (1996). Investigation of the inter-
action of m-calpain with phospholipids: calpain-phospholipid
interactions. Biochim. Biophys. Acta 1293, 201–206.
Barry, J.K., Selinger, D.A., Wang, C., Olsen, O.-A. and Rao, A.G.
(2006). Biochemical characterization of a truncated penta-
EF-hand Ca2q binding protein from maize. Biochim. Biophys.
Acta 1764, 239–245.
Bazzi, M.D. and Nelsestuen, G.L. (1987). Association of protein
kinase C with phospholipid vesicles. Biochemistry 26,
115–122.
Bittova, L., Sumandea, M., and Cho, W. (1999). A structure-func-
tion study of the C2 domain of cytosolic phospholipase A2.
Identification of essential calcium ligands and hydrophobic
membrane binding residues. J. Biol. Chem. 274, 9665–9672.
Bolsover, S.R., Gomez-Fernandez, J.C., and Corbalan-Garcia,S.
(2003). Role of the Ca2q/phosphatidylserine binding region of
the C2 domain in the translocation of protein kinase Ca to
the plasma membrane. J. Biol. Chem. 278, 10282–10290.
Brand, L. and Gohlke, J.R. (1972). Fluorescence probes for
structure. Annu. Rev. Biochem. 41, 843–868.
Brandenburg, K., Harris, F., Dennison, S., Seydel, U., and Phoe-
nix, D. (2002). Domain V of m-calpain shows the potential to
form an oblique-orientated a-helix, which may modulate the
enzyme’s activity via interactions with anionic lipid. Eur. J.
Biochem. 269, 5414–5422.
Cho, W. (2001). Membrane targeting by C1 and C2 domains.
J. Biol. Chem. 276, 32407–32410.
Cho, W., Bittova, L., and Stahelin, R.V. (2001). Membrane bind-
ing assays for peripheral proteins. Anal. Biochem. 296,
153–161.
Cong, J., Goll, D.E., Peterson, A.M., and Kapprell, H.P. (1989).
The role of autolysis in activity of the Ca2q-dependent pro-
teinases (m-calpain and m-calpain). J. Biol. Chem. 264,
10096–10103.
Coolican, S.A. and Hathaway, D.R. (1984). Effect of L-a-phos-
phatidylinositol on a vascular smooth muscle Ca2q-depend-
ent protease. Reduction of the Ca2q requirement for
autolysis. J. Biol. Chem. 259, 11627–11630.
Crawford, C., Brown, N.R., and Willis, A.C. (1990). Investigation
of the structural basis of the interaction of calpain II with
phospholipid and with carbohydrate. Biochem. J. 265,
575–579.
Dainese, E., Minafra, R., Sabatucci, A., Vachette, P., Melloni, E.,
and Cozzani, I. (2002). Conformational changes of calpain
from human erythrocytes in the presence of Ca2q. J. Biol.
Chem. 277, 40296–40301.
Das, S., Dixon, J.E., and Cho, W. (2003). Membrane-binding and
activation mechanism of PTEN. Proc. Natl. Acad. Sci. USA
100, 7491–7496.
Dennison, S.R., Dante, S., Hauss, T., Brandenburg, K., Harris, F.,
and Phoenix, D.A. (2005). Investigations into the membrane
interactions of m-calpain domain V. Biophys. J. 88, 3008–
3017.
Diaz, B.G., Gross, S., Assfalg-Machleidt, I., Pfeiler, D., Gollmit-
zer, N., Gabrijelcic-Geiger, D., Stubbs, M.T., Fritz, H., Auers-
wald, E.A. and Machleidt, W. (2001). Cystatins as calpain
inhibitors: engineered chicken cystatin- and stefin B-kinino-
gen domain 2 hybrids support a cystatin-like mode of inter-
action with the catalytic subunit of m-calpain. Biol. Chem.
382, 97–107.
Dutt, P., Arthur, J.S., Grochulski, P., Cygler, M., and Elce, J.S.
(2000). Roles of individual EF-hands in the activation of
m-calpain by calcium. Biochem. J. 348, 37–43.
Elce, J.S., Davies, P.L., Hegadorn, C., Maurice, D.H. and Arthur,
J.S. (1997). The effects of truncations of the small subunit on
m-calpain activity and heterodimer formation. Biochem. J.
326, 31–38.
Erb, E.M., Chen, X., Allen, S., Roberts, C.J., Tendler, S.J.,
Davies, M.C., and Forsen, S. (2000). Characterization of the
surfaces generated by liposome binding to the modified dex-
tran matrix of a surface plasmon resonance sensor chip.
Anal. Biochem. 280, 29–35.
Fernandez-Chacon, R., Shin, O.H., Konigstorfer, A., Matos, M.F.,
Meyer, A.C., Garcia, J., Gerber, S.H., Rizo, J., Sudhof, T.C.,
and Rosenmund, C. (2002). Structure/function analysis of
Ca2q binding to the C2A domain of synaptotagmin 1. J. Neu-
rosci. 22, 8438–8446.
Fernandez-Montalvan, A., Assfalg-Machleidt, I., Pfeiler, D., Fritz,
H., Jochum, M., and Machleidt, W. (2004). Electrostatic inter-
actions of domain III stabilize the inactive conformation ofm-
calpain. Biochem. J. 382, 607–617.
Friedrich, P. (2004). The intriguing Ca2q requirement of cal-
pain activation. Biochem. Biophys. Res. Commun. 323,
1131–1133.
Gabrijelcic-Geiger, D., Mentele, R., Meisel, B., Hinz, H., Assfalg-
Machleidt, I., Machleidt, W., Mo¨ller, A., and Auerswald, E.A.
(2001). Human m-calpain: simple isolation from erythrocytes
and characterization of autolysis fragments. Biol. Chem. 382,
1733–1737.
Gerke, V. and Moss, S.E. (2002). Annexins: from structure to
function. Physiol. Rev. 82, 331–371.
Gil-Parrado, S., Popp, O., Knoch, T.A., Zahler, S., Bestvater, F.,
Felgentrager, M., Holloschi, A., Fernandez-Montalvan, A.,
Auerswald, E.A., Fritz, H., et al. (2003). Subcellular localiza-
tion and in vivo subunit interactions of ubiquitous m-calpain.
J. Biol. Chem. 278, 16336–16346.
Glading, A., Bodnar, R.J., Reynolds, I.J., Shiraha, H., Satish, L.,
Potter, D.A., Blair, H.C., and Wells, A. (2004). Epidermal
growth factor activates m-calpain (calpain II), at least in part,
Membrane binding of m-calpain 627
Article in press - uncorrected proof
by extracellular signal-regulated kinase-mediated phospho-
rylation. Mol. Cell. Biol. 24, 2499–2512.
Goll, D.E., Thompson, V.F., Li, H., Wei, W., and Cong, J. (2003).
The calpain system. Physiol. Rev. 83, 731–801.
Hatanaka, M., Yoshimura, N., Murakami, T., Kannagi, R., and
Murachi, T. (1984). Evidence for membrane-associated cal-
pain I in human erythrocytes. Detection by an immunoelec-
trophoretic blotting method using monospecific antibody.
Biochemistry 23, 3272–3276.
Hong, H., el-Saleh, S.C., and Johnson, P. (1990). Fluorescence
spectroscopic analysis of calpain II interactions with calcium
and calmodulin antagonists. Int. J. Biochem. 22, 399–404.
Hood, J.L., Brooks, W.H., and Roszman, T.L. (2004). Differential
compartmentalization of the calpain/calpastatin network with
the endoplasmic reticulum and Golgi apparatus. J. Biol.
Chem. 279, 43126–43135.
Imajoh, S., Kawasaki, H., and Suzuki, K. (1986). The amino-ter-
minal hydrophobic region of the small subunit of cal-
cium-activated neutral protease (CANP) is essential for its
activation by phosphatidylinositol. J. Biochem. (Tokyo) 99,
1281–1284.
Inomata, M., Saito, Y., Kon, K., and Kawashima, S. (1990). Bind-
ing sites for calcium-activated neutral protease on erythro-
cyte membranes are not membrane phospholipids. Biochem.
Biophys. Res. Commun. 171, 625–632.
Kim, Y., Lichtenbergova, L., Snitko, Y., and Cho, W. (1997). A
phospholipase A2 kinetic and binding assay using phospho-
lipid-coated hydrophobic beads. Anal. Biochem. 250,
109–116.
Li, H., Thompson, V.F., and Goll, D.E. (2004). Effects of autolysis
on properties of m- and m-calpain. Biochim. Biophys. Acta
1691, 91–103.
Maki, M., Kitaura, Y., Satoh, H., Ohkouchi, S., and Shibata, H.
(2002). Structures, functions and molecular evolution of the
penta-EF-hand Ca2q-binding proteins. Biochim. Biophys.
Acta 1600, 51–60.
Matsumura, Y., Saeki, E., Otsu, K., Morita, T., Takeda, H.,
Kuzuya, T., Hori, M., and Kusuoka, H. (2001). Intracellular
calcium level required for calpain activation in a single myo-
cardial cell. J. Mol. Cell. Cardiol. 33, 1133–1142.
Melloni, E., Michetti, M., Salamino, F., and Pontremoli, S. (1998).
Molecular and functional properties of a calpain acti-
vator protein specific for m-isoforms. J. Biol. Chem. 273,
12827–12831.
Minami, Y., Emori, Y., Kawasaki, H., and Suzuki, K. (1987). E-F
hand structure-domain of calcium-activated neutral protease
(CANP) can bind Ca2q ions. J. Biochem. (Tokyo) 101,
889–895.
Moldoveanu, T., Hosfield, C.M., Lim, D., Elce, J.S., Jia, Z., and
Davies, P.L. (2002). A Ca2q switch aligns the active site of
calpain. Cell 108, 649–660.
Moldoveanu, T., Jia, Z., and Davies, P.L. (2004). Calpain activa-
tion by cooperative Ca2q binding at two non-EF-hand sites.
J. Biol. Chem. 279, 6106–6114.
Murray, D. and Honig, B. (2002). Electrostatic control of the
membrane targeting of C2 domains. Mol. Cell 9, 145–154.
Nalefski, E.A. and Falke, J.J. (2002). Use of fluorescence reso-
nance energy transfer to monitor Ca2q-triggered membrane
docking of C2 domains. Methods Mol. Biol. 172, 295–303.
Niinobe, M., Yamaguchi, Y., Fukuda, M., and Mikoshiba, K.
(1994). Synaptotagmin is an inositol polyphosphate binding
protein: isolation and characterization as an Ins1,3,4,5-P4
binding protein. Biochem. Biophys. Res. Commun. 205,
1036–1042.
Ono, Y., Kakinuma, K., Torii, F., Irie, A., Nakagawa, K., Labeit, S.,
Abe, K., Suzuki, K., and Sorimachi, H. (2004). Possible reg-
ulation of the conventional calpain system by skeletal mus-
cle-specific calpain, p94/calpain 3. J. Biol. Chem. 279,
2761–2771.
Pal, G.P., Elce, J.S., and Jia, Z. (2001). Dissociation and aggre-
gation of calpain in the presence of calcium. J. Biol. Chem.
276, 47233–47238.
Pontremoli, S., Melloni, E., Sparatore, B., Salamino, F., Michetti,
M., Sacco, O., and Horecker, B.L. (1985). Role of phospho-
lipids in the activation of the Ca2q-dependent neutral pro-
teinase of human erythrocytes. Biochem. Biophys. Res.
Commun. 129, 389–395.
Rizo, J. and Sudhof, T.C. (1998). C2-domains, structure and
function of a universal Ca2q-binding domain. J. Biol. Chem.
273, 15879–15882.
Saido, T.C., Mizuno, K., and Suzuki, K. (1991). Proteolysis of
protein kinase C by calpain: effect of acidic phospholipids.
Biomed. Biochim. Acta 50, 485–489.
Saido, T.C., Shibata, M., Takenawa, T., Murofushi, H., and Suzu-
ki, K. (1992). Positive regulation of m-calpain action by poly-
phosphoinositides. J. Biol. Chem. 267, 24585–24590.
Saido, T.C., Suzuki, H., Yamazaki, H., Tanoue, K., and Suzuki,
K. (1993). In situ capture of m-calpain activation in platelets.
J. Biol. Chem. 268, 7422–7426.
Samis, J.A. and Elce, J.S. (1989). Immunogold electron-micro-
scopic localization of calpain I in human erythrocytes.
Thromb. Haemost. 61, 250–253.
Stahelin, R.V., Rafter, J.D., Das, S., and Cho, W. (2003). The
molecular basis of differential subcellular localization of C2
domains of protein kinase C-alpha and group IVa cytosolic
phospholipase A2. J. Biol. Chem. 278, 12452–12460.
Strobl, S., Fernandez-Catalan, C., Braun, M., Huber, R., Masu-
moto, H., Nakagawa, K., Irie, A., Sorimachi, H., Bourenkow,
G., Bartunik, H., et al. (2000). The crystal structure of calci-
um-free human m-calpain suggests an electrostatic switch
mechanism for activation by calcium. Proc. Natl. Acad. Sci.
USA 97, 588–592.
Suzuki, K., Imajoh, S., Emori, Y., Kawasaki, H., Minami, Y., and
Ohno, S. (1987). Calcium-activated neutral protease and its
endogenous inhibitor. Activation at the cell membrane and
biological function. FEBS Lett. 220, 271–277.
Tait, J.F., Gibson, D., and Fujikawa, K. (1989). Phospholipid bind-
ing properties of human placental anticoagulant protein-I, a
member of the lipocortin family. J. Biol. Chem. 264,
7944–7949.
Tompa, P., Baki, A., Schad, E., and Friedrich, P. (1996). The cal-
pain cascade. m-calpain activates m-calpain. J. Biol. Chem.
271, 33161–33164.
Tompa, P., Emori, Y., Sorimachi, H., Suzuki, K., and Friedrich, P.
(2001). Domain III of calpain is a Ca2q-regulated phospholip-
id-binding domain. Biochem. Biophys. Res. Commun. 280,
1333–1339.
Weiss, J. (1997). The Hill equation revisited: uses and misuses.
FASEB J. 11, 835–841.
Wendt, A., Thompson, V.F., and Goll, D.E. (2004). Interaction of
calpastatin with calpain: a review. Biol. Chem. 385, 465–472.
Zalewska, T., Thompson, V.F., and Goll, D.E. (2004). Effect of
phosphatidylinositol and inside-out erythrocyte vesicles on
autolysis of m- and m-calpain from bovine skeletal muscle.
Biochim. Biophys. Acta 1693, 125–133.
Received January 13, 2006; accepted March 13, 2006
